phase readout
saveNCT03854110: A Trial to Evaluate Safety, Tolerability, and Preliminary Efficacy of Misetionamide (GP-2250) as Monotherapy or in Combination With Gemcitabine
RECRUITINGupdated 17h ago
community read0 votes
Sponsor: Persevere Therapeutics Inc.. Phase: PHASE1. Conditions: Ovarian Cancer
view source ↗
comments(0)
5-min edit window · permanent after that